What Happened?

Celltrion decided to dispose of 7,043 treasury shares (approximately 1 billion KRW) on July 23, 2025. This was for the purpose of allocating treasury shares following the exercise of stock options.

Why the Disposal?

This treasury stock disposal is part of the company’s general business operations, specifically for the exercise of employee stock options. Therefore, the direct impact on Celltrion’s fundamentals is expected to be minimal. This is because the disposed quantity represents a very small portion (0.017%) of the total outstanding shares.

So, What’s the Impact on the Stock Price?

The treasury stock disposal itself is not expected to significantly impact the stock price. Short-term stock fluctuations are likely a temporary market reaction. Celltrion’s stock price will be influenced in the long term by factors such as the sustainability of Q1 earnings, intensifying competition in the biosimilar market, the success of new drug development, and changes in the macroeconomic environment. Recent increased volatility in the KRW/USD exchange rate and the possibility of US interest rate hikes present macroeconomic uncertainties. Furthermore, fluctuations in raw material prices can also affect Celltrion’s profitability.

What Should Investors Do?

Investors should focus on Celltrion’s fundamentals and changes in the macroeconomic environment rather than reacting to short-term stock fluctuations. It is crucial to carefully monitor earnings announcements after Q2, news related to new drug development, and the competitive landscape of the biosimilar market. Moreover, Celltrion’s risk management capabilities, such as strategies to manage raw material price fluctuation risks, will be important factors in investment decisions. If you have a positive long-term outlook on Celltrion’s growth potential, you could consider using short-term price fluctuations as an opportunity to increase your holdings. However, investment decisions should always be made carefully, and it’s advisable to consult with a financial advisor.